CN Patent

CN101743241B — 哒嗪酮衍生物

Assigned to Merck Patent GmbH · Expires 2013-12-25 · 12y expired

What this patent protects

式(I)化合物是酪氨酸激酶、尤其是Met激酶的抑制剂，其中R 1 、R 2 、R 3 、R 4 和R 4 ′各自如权利要求(1)中所定义，该化合物尤其可用于治疗肿瘤。

USPTO Abstract

式(I)化合物是酪氨酸激酶、尤其是Met激酶的抑制剂，其中R 1 、R 2 、R 3 、R 4 和R 4 ′各自如权利要求(1)中所定义，该化合物尤其可用于治疗肿瘤。

Drugs covered by this patent

tepotinib-hydrochloride (TEPOTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN101743241B
Jurisdiction: CN
Classification: —
Expires: 2013-12-25
Drug substance claim: No
Drug product claim: No
Assignee: Merck Patent GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.